Evidence map›Paper›PMID 35968390›Full record

ArticleFrontiers in neuroscience2022

Vitamin D serum level predicts stroke clinical severity, functional independence, and disability-A retrospective cohort study.

Abdullah R Alharbi, Amer S Alali, Yahya Samman, Nouf A Alghamdi, Omar Albaradie, Maan Almaghrabi, Seraj Makkawi, Saeed Alghamdi, Mohammad S Alzahrani, Mohammed Alsalmi and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. The Effects of Cannabinoids on Ischemic Stroke-Associated Neuroinflammation: A Systematic Review.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 2 countries.

Abdullah R AlharbiKing Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Amer S AlaliDepartment of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
Yahya SammanKing Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Nouf A AlghamdiKing Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Omar AlbaradieKing Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Maan AlmaghrabiKing Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Seraj MakkawiKing Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Saeed AlghamdiKing Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Mohammad S AlzahraniDepartment of Clinical Pharmacy, College of Pharmacy, Taif University, Taif, Saudi Arabia.
Mohammed AlsalmiKing Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Vardan T KaramyanDepartment of Pharmaceutical Sciences, Jerry. H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX, United States.
Khalid Al SulaimanDepartment of Pharmaceutical Care, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Ohoud AljuhaniDepartment of Pharmacy Practice, King Abdulaziz University, Jeddah, Saudi Arabia.
Faisal F AlamriKing Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
King Abdullah International Medical Research Center · SAKing Saud bin Abdulaziz University for Health Sciences · SAKing Abdulaziz Medical City · SAKing Abdulaziz University · SAKing Salman Center for Disability Research · SAPrince Sattam Bin Abdulaziz University · SATaif University · SATexas Tech University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Stroke is a leading cause of mortality and disability and one of the most common neurological conditions globally. Many studies focused on vitamin D as a stroke risk factor, but only a few focused on its serum level as a predictor of stroke initial clinical severity and recovery with inconsistent results. The purpose of this study was to assess the relationship between serum vitamin D levels and stroke clinical severity at admission and functional independence and disability at discharge in Saudi Arabia. Methodology: A retrospective cohort study of adult ischemic stroke patients who had their vitamin D tested and admitted within 7 days of exhibiting stroke symptoms at King Abdulaziz Medical City (KAMC) Jeddah, Saudi Arabia. Based on vitamin D level, the patients were categorized into normal [25(OH)D serum level ≥ 75 nmol/L], insufficient [25(OH)D serum level is 50-75 nmol/L], and deficient [25(OH)D serum level ≤ 50 nmol/L]. The primary outcome was to assess the vitamin D serum level of ischemic stroke patients' clinical severity at admission and functional independence at discharge. The National Institute of Health Stroke Scale (NIHSS) was used to assess the clinical severity, whereas the modified Rankin scale (mRS) was used to assess functional independence and disability. Results: The study included 294 stroke patients, out of 774, who were selected based on the inclusion and exclusion criteria. The mean age of the participants was 68.2 ± 13.4 years, and 49.3% were male. The patients' distribution among the three groups based on their vitamin D levels is: normal ( Conclusion: Low vitamin D levels were associated with higher severity of stroke at admission and poor functional independence and disability at discharge in patients with acute ischemic stroke. Further randomized clinical and interventional studies are required to confirm our findings.

Indexed as

25(OH)Ddisabilitymodified Rankin scale (mRS)NIHSS scorepreventionrecoverystrokevitamin D

Identifiers

PMID35968390
PMCPMC9363625
OpenAlexW4288034279

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.